An Unusual Trifecta: Dermatillomania, Psoriasis, & MRSA in a Rare Case of Primary Cutaneous Gamma/Delta T-Cell Lymphoma
Main Article Content
Keywords
cutaneous lymphoma, t-cell lymphoma, CTCL, MRSA, Staphylococcus auries, skin picking, excoriation disorder, dermatillomania, psorasis, pruritis
Abstract
Primary cutaneous gamma/delta T-cell lymphoma (PCγδTCL) is one of twelve known cutaneous T-cell lymphoma (CTCL) rare subtypes comprising of less than 1-2% of all cutaneous lymphomas. These subtypes may have either an indolent or aggressive clinical course, or may be co-existent with other dermatological, infectious, or psychiatric conditions. Based on our literature review, we were unable to find documented cases involving all three aspects of possible co-existing conditions in one patient. We present case of a 61-year-old Caucasian male diagnosed with biopsy-confirmed primary cutaneous gamma/delta T-cell lymphoma with dermatillomania, psoriasis, and MRSA.
References
2. Scott J, Lai C, Coltart G, Bates A, Bennett L, Sommerland M, Foria V, & Healy E. Coexistance of psoriasis and cutaneous T-cell lymphoma. Clin Exp Dermatol. 2023. 00:1-5. doi: 10.1093/ced/llad213
3. Misery L, Carstens E & Akiyama T. Ch. 8: Pruritis in cutaneous T-cell lymphoma in Itch: mechanisms and treatment. 2014. Boca Raton (FL): CRC Press/Taylor & Francis.
4. Emge DA, Bassett RL, Duvic M, & Huen AO. Methicillin-resistant Staphylococcus aures (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients. Archiv Dermol Resear. 2020; 312:283-288. doi:10.007/s00403-019-0215-7.
5. Damiani G, Tacastacas JD, Wuerz T, Miller L, Fastenau P, Bailey C, Sethi MC, Argenas A, Fiore M, Cooper KD, & Lerner AJ. Cognitive/psychological burden and resilience in cutaneous T-cell lymphoma and psoriasis patients: real-life data and implications for the treatment. Hindawi BioMed Resear Internat. 2022. 1-10. doi: 10.1155/2022/8802469
6. Zain JM & Hanona P. Aggressive T-cell lymphomas: 2021 Updates on diagnosis, risk
stratification and management. Am J Hematol. 2021; 96:1027-1046. doi.org/10.1002/ajh.26270.
7. Koch R, Jaffe E, Mensing C, Zeis M, Schmitz N, & Sander C. Cutaneous gamma/delta T-cell lymphoma. J Dtsch Dermatol Ges. 2009. 7(12): 1065-1067. doi: 10.1111/j.1610-0387.2009.07209.x.
8. Sateesh BA, Bhagat YV, Thomas SE, Sood A, & Michael MB. Recurrent bacterial infections in cutaneous T-cell lymphoma. Cureus. 2022. 14(1):e20912. doi: 10.7759/cureus.20912
9. Diakomopoulos, A, Dalamaga, M, & Papadavid, E. (2021). Understanding the enigmatic association between mycosis fungoides and psoriasis: Report of two cases and review of the literature. Metabo Open. 2021: 12,100148. doi:10.1016/j.metop.2021.100148
10. Muhsen, IN, El Fakih, R, Hamadani, M. et al. Clinical, diagnostic, and prognostic characteristics of primary cutaneous gamma delta T-cell lymphomas. Clin Hematol Int. 2022. 4: 1–10. doi:10.1007/s44228-022-00011-9
11. Rubio-Gonzalez B, Zain J, Garcia L, Rosen ST, Querfeld C. Cutaneous gamma-delta T-cell lymphoma successfully treated with brentuximab vedotin. JAMA Dermatol. 2016. 152(12):1388–1390. doi:10.1001/jamadermatol.2016.3117
12. Porkert S, Lehner-Baumgartner E, Valencak J, Knobler R, Riedl E, & Jonak C. Patients’ illness perception as a tool to improve individual disease management in primary cutaneous lymphomas. Acta Derm Venereol. 2018. 98: 240-245. doi:10.2340/00015555-2819
13. Otevanger, R, Van Beugen, S, Evers, AWM, Willemze, R, Vermeer, MH, & Quint, KD. (2022). Itch in patients with cutaneous T-cell lymphoma as a quality-of-life indicator. JAAD international. 2022. 9: 57–64. doi: 0.1016/j.jdin.2022.07.007
14. Row B & Yosipovitch G. Malignancy-associated pruritus. Euro J Pain. 2016. 20(19): 19-23. doi:10.1002/ejp.760
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.